Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
Abstract The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of a...
Guardado en:
Autores principales: | James J. Hoy, Georgios Kallifatidis, Diandra K. Smith, Bal L. Lokeshwar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d694f9f3e8db41efa65a4e39eb7119d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
por: N. V. Kipich, et al.
Publicado: (2014) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Aasems Jacob, et al.
Publicado: (2021) -
Androgen receptor-binding sites are highly mutated in prostate cancer
por: Tunç Morova, et al.
Publicado: (2020) -
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
por: Weiyuan Li, et al.
Publicado: (2021) -
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
por: Emma Hörnberg, et al.
Publicado: (2011)